; Whereas access to vaccines is an essential part of ending preventable childhood deaths and preventing other fatal diseases; Whereas, in August 2019, the GAVI Alliance called on donors to support an ambitious plan to immunize an additional 300,000,000 children against potentially fatal diseases between 2021 and 2025, and save an additional 7,000,000 to 8,000,000 lives; Whereas GAVI-eligible countries are expected to contribute $3,600,000,000 of their own domestic funding toward their vaccine programs in the GAVI Alliance’s 2021–2025 strategic period, more than doubling their funding from the $1,600,000,000 contributed during the 2015–2020 period; Whereas the third GAVI replenishment conference will be held in June 2020 hosted by the United Kingdom to obtain funding commitments to support the organization’s programs from 2021 to 2025; Whereas the GAVI Alliance needs donors to invest at least an additional $7,400,000,000 for its third replenishment cycle to support developing countries’ immunization programs from 2021 to 2025; Whereas the United States has consistently supported the goal of saving lives by contributing to the GAVI Alliance to meet its projected replenishment and program goals; Whereas the United States has made contributions to the GAVI Alliance in the amount of $290,000,000 in each of fiscal years 2018 and 2019, and has appropriated this amount for fiscal year 2020; Whereas with this support and support from other donors, the GAVI Alliance will have contributed to saving more than 20,000,000 lives by the end of 2025 and unlocked between $80,000,000 to $100,000,000 in economic benefits through health care savings and productivity gains; and Whereas a strong commitment from the United States remains necessary to ensure predictability and stability to the vaccine market, to enable strong global health security efforts, spur confidence in GAVI-eligible countries, and encourage continued innovative vaccine-related approaches: Now, therefore, be it